Biocon Ltd. (BIOCON) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 201791,
    "name": "Biocon",
    "stock_name": "Biocon",
    "full_name": "Biocon Ltd.",
    "name_url": "stocks-analysis/biocon",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "388.20",
    "chg": -0.05,
    "chgp": "-0.01%",
    "dir": -1,
    "prev_price": "388.25",
    "mcapval": "51,900.93 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532523,
    "symbol": "BIOCON",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE376G01013",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "3.34 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Biocon Ltd. Sees Significant Open Interest Surge Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-sees-sharp-open-interest-surge-amidst-volatile-trading-market-positioning-signals-caution-3746921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Biocon_oi_spurts_by_underlying_3746921.png",
        "date": "2025-12-04 15:00:09",
        "description": "Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest within its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes amid a backdrop of recent price volatility and changing volume dynamics, prompting closer scrutiny of potential directional bets and market sentiment."
      },
      {
        "title": "Biocon Ltd. Sees Significant Open Interest Surge Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-sees-sharp-open-interest-surge-amid-volatile-trading-market-positioning-signals-caution-3746857",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Biocon_oi_spurts_by_underlying_3746857.png",
        "date": "2025-12-04 14:00:09",
        "description": "Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge in open interest within its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes amid a backdrop of recent price volatility and changing volume dynamics, prompting closer scrutiny of potential directional bets and market sentiment."
      },
      {
        "title": "Biocon Ltd Sees Significant Surge in Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-sees-sharp-open-interest-surge-amidst-volatile-trading-3746788",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Biocon_oi_spurts_by_underlying_3746788.png",
        "date": "2025-12-04 13:00:06",
        "description": "Biocon Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes amid a backdrop of recent price volatility and changing volume dynamics, offering insights into potential directional bets by market participants."
      },
      {
        "title": "Biocon Ltd Sees Notable Surge in Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-sees-sharp-open-interest-surge-amidst-volatile-trading-3746722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Biocon_oi_spurts_by_underlying_3746722.png",
        "date": "2025-12-04 12:00:07",
        "description": "Biocon Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes amid a backdrop of recent price volatility and changing volume patterns, offering insights into potential directional bets by market participants."
      },
      {
        "title": "Biocon . Shares Hit Intraday Low Amid Price Pressure and Market Headwinds",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-shares-hit-intraday-low-amid-price-pressure-on-4-dec-2025-3746727",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Biocon_priceRelatedfactors_3746727.png",
        "date": "2025-12-04 11:56:33",
        "description": "Shares of Biocon . experienced notable intraday weakness on 4 Dec 2025, touching a low of Rs 388, reflecting a decline of 5.4% from previous levels. This downturn occurred despite a broadly positive market environment, with the Sensex recovering to trade marginally higher by 0.1%."
      },
      {
        "title": "Biocon Ltd. Sees Notable Surge in Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-sees-sharp-open-interest-surge-amid-mixed-price-action-and-rising-investor-participation-3746621",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Biocon_oi_spurts_by_underlying_3746621.png",
        "date": "2025-12-04 11:00:11",
        "description": "Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of recent price fluctuations and shifting volume patterns, offering insights into potential directional bets and market sentiment."
      },
      {
        "title": "Biocon’s Evaluation Revised Amid Mixed Financial and Market Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-upgraded-from-sell-to-hold-by-marketsmojo-on-13-oct-2025-3731065",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Biocon_mojoScore_3731065.png",
        "date": "2025-11-26 09:46:01",
        "description": "Biocon’s recent assessment has been revised, reflecting a shift in market evaluation driven by a combination of valuation appeal, technical momentum, and financial challenges. The pharmaceutical and biotechnology company’s midcap status and recent stock performance provide important context for investors analysing its evolving outlook."
      },
      {
        "title": "Biocon Ltd Sees Heavy Put Option Activity Amid Bearish Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-sees-heavy-put-option-activity-amid-bearish-sentiment-and-price-pressure-3717562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Biocon_most_active_stocks_puts_3717562.png",
        "date": "2025-11-20 10:00:10",
        "description": "Biocon Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed significant put option trading activity ahead of the 25 November 2025 expiry. The surge in put contracts at strike prices near the current market value signals a cautious or bearish stance among investors, reflecting broader market dynamics and sector-specific pressures."
      },
      {
        "title": "Biocon Ltd: High-Value Trading and Institutional Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-high-value-trading-amidst-declining-momentum-and-institutional-caution-3717560",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Biocon_most_active_equities_by_value_3717560.png",
        "date": "2025-11-20 10:00:10",
        "description": "Biocon Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 20 Nov 2025. Despite a downward price movement, the stock continues to attract significant trading volumes and institutional participation, reflecting ongoing investor interest amid a fluctuating market environment."
      }
    ],
    "total": 5751,
    "sid": "201791",
    "stock_news_url": "https://www.marketsmojo.com/news/biocon-201791"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "02-Dec-2025",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Company Statement",
      "datetime": "27-Nov-2025",
      "details": "Company Statement",
      "source": "BSE"
    },
    {
      "caption": "Notification",
      "datetime": "19-Nov-2025",
      "details": "Notification",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 04 Jul 25",
          "dt": "2025-07-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19",
          "dt": "2019-06-12",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biocon Ltd. Sees Significant Open Interest Surge Amid Market Volatility

2025-12-04 15:00:09

Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest within its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes amid a backdrop of recent price volatility and changing volume dynamics, prompting closer scrutiny of potential directional bets and market sentiment.

Biocon Ltd. Sees Significant Open Interest Surge Amid Market Volatility

2025-12-04 14:00:09

Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge in open interest within its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes amid a backdrop of recent price volatility and changing volume dynamics, prompting closer scrutiny of potential directional bets and market sentiment.

Biocon Ltd Sees Significant Surge in Open Interest Amid Market Volatility

2025-12-04 13:00:06

Biocon Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes amid a backdrop of recent price volatility and changing volume dynamics, offering insights into potential directional bets by market participants.

Biocon Ltd Sees Notable Surge in Open Interest Amid Market Volatility

2025-12-04 12:00:07

Biocon Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes amid a backdrop of recent price volatility and changing volume patterns, offering insights into potential directional bets by market participants.

Biocon . Shares Hit Intraday Low Amid Price Pressure and Market Headwinds

2025-12-04 11:56:33

Shares of Biocon . experienced notable intraday weakness on 4 Dec 2025, touching a low of Rs 388, reflecting a decline of 5.4% from previous levels. This downturn occurred despite a broadly positive market environment, with the Sensex recovering to trade marginally higher by 0.1%.

Biocon Ltd. Sees Notable Surge in Open Interest Amid Market Volatility

2025-12-04 11:00:11

Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of recent price fluctuations and shifting volume patterns, offering insights into potential directional bets and market sentiment.

Biocon’s Evaluation Revised Amid Mixed Financial and Market Signals

2025-11-26 09:46:01

Biocon’s recent assessment has been revised, reflecting a shift in market evaluation driven by a combination of valuation appeal, technical momentum, and financial challenges. The pharmaceutical and biotechnology company’s midcap status and recent stock performance provide important context for investors analysing its evolving outlook.

Biocon Ltd Sees Heavy Put Option Activity Amid Bearish Market Sentiment

2025-11-20 10:00:10

Biocon Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed significant put option trading activity ahead of the 25 November 2025 expiry. The surge in put contracts at strike prices near the current market value signals a cautious or bearish stance among investors, reflecting broader market dynamics and sector-specific pressures.

Biocon Ltd: High-Value Trading and Institutional Interest Amid Market Volatility

2025-11-20 10:00:10

Biocon Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 20 Nov 2025. Despite a downward price movement, the stock continues to attract significant trading volumes and institutional participation, reflecting ongoing investor interest amid a fluctuating market environment.

View All News